ELAN News

Latest breaking news and updates for ELAN stock.

Track all markets on TradingView

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE: ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brook...

Are there broader sector implications or spill‑over effects for other animal‑health and biotech stocks resulting from this swap, and what does this mean for trade‑level strategies? What impact will the index rebalancing have on institutional and ETF allocations to ELAN and Sarepta Therapeutics, and how might this drive price movements? How will Elanco Animal Health's inclusion in the S&P MidCap 400 affect its short‑term price dynamics and trading volume?
Index
1 day ago
Read more prnewswire

Elanco Animal Health Reports Second Quarter 2025 Results

Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2025 Financial Results: Revenue of $1,241 million, an increase of 5% year-over-year; 8% ...

How does the current sentiment score of 35 align with market expectations and potential upside or downside scenarios? Is there any indication of future capital allocation plans (e.g., R&D spend, M&A, share repurchases) that could affect the stock? What risks remain that could derail the raised full‑year outlook, such as regulatory, supply chain, or competitive pressures?
Earnings
21 days ago
Read more prnewswire